Sonosemi Medical

Sonosemi Medical Co., Ltd., founded in April 2020 in Shenzhen, the epicenter of scientific and technological advancements in China, is an innovative enterprise specializing in high-end pan-vascular interventional medical devices. Sonosemi Medical has designed its products in accordance with the open industry synergy strategy and the business logic of integrating research, production, and sales. The company's products are centered on the clinical application scenarios of coronary artery disease, peripheral vascular disease, and structural heart disease. Its goal is to provide the cardiovascular disease diagnostic and treatment industry with a series of intelligent and precise product solutions. Sonosemi is presently recognized in China for having the inaugural domestic coronary intravascular lithotripsy system approved, the first domesticintracardiac echocardiography (ICE) system that has entered the green channel of the NMPA for innovative medical devices in China, and the imminent approval and commercialization of the peripheral artery lithotripsy system. Additionally, numerous innovative products are currently undergoing research and development. Sonosemi possesses the intellectual property rights to each product in an independent capacity. Sonosemi Medical has assembled approximately two hundred scientific research elites and operation talents who possess senior-level experience in the medical device industry. The organization is collaborating with domestic and international partners to advance the commercialization of cutting-edge medical devices, generate value for physicians and patients, and serve as a catalyst for intelligent healthcare.

• Employees 4
• Founded 2020